Score 0-20: Openly advocates a binding trade-rule instrument restricting cross-border pharma flows. Required signatures (one or more must be present): (a) explicit call for an EU-wide tariff, quota, import licensing requirement, export ban or export-control regime on pharmaceuticals; (b) explicit sanitary or quality-standard threshold framed as a barrier to imports from weaker-standard third countries; (c) explicit Buy-European pharma procurement preference applied via trade-rule instrument (NOT via production mandate -- production mandates route to topic 162). DEPENDENCE-REDUCTION FRAMING ALONE (without a named trade instrument) IS NOT SUFFICIENT for bracket 0-20 -- such rows typically route to topic 162 per GUIDANCE point 7. Score 21-40: Subtly favours restricting flows via trade instruments -- conditional tariffs, slow-walking trade-liberalisation talks on pharma, soft EU-content preference applied via trade rule, sanitary controls being used as effective trade barrier without explicit framing. Score 41-60: RARE. Genuine balance only. Score 61-80: Subtly favours open trade. Defends regulatory cooperation/mutual-recognition with non-EU partners, opposes specific protectionist measures, defends current tariff lines against retaliatory escalation, without rejecting strategic autonomy framings outright. Score 81-100: Openly defends open global pharma trade. Opposes Buy-European in trade-rule form, rejects onshoring-via-trade-barriers, frames protectionism on essential medicines as harmful to access, supports broad pharma-chapter liberalisation in FTAs.